Content of Standard·Strategy·Guidelines in our journal

        Published in last 1 year |  In last 2 years |  In last 3 years |  All
    Please wait a minute...
    For Selected: Toggle Thumbnails
    Expert Consensus on Primary Health Governance 2024
    Public Health Security and Health Professional Committee of the Public Safety Science and Technology Society, General Practitioner Branch of Chinese Medical Doctor Association
    Chinese General Practice    2025, 28 (01): 13-19.   DOI: 10.12114/j.issn.1007-9572.2024.0264
    Abstract624)   HTML17)    PDF(pc) (1294KB)(329)       Save

    Primary health governance is a crucial part of the national health governance system and plays a key role in achieving universal health. However, primary health governance currently faces many challenges. The Expert Consensus on Primary Health Governance is led by the Public Health Security and Health Professional Committee of the Public Safety Science and Technology Society, in collaboration with experts from multiple disciplines. The aim of this consensus is to integrate evidence-based scientific evidence, practical wisdom, and experience from multidisciplinary experts in primary health-related fields. This consensus addresses the connotations, significance, objectives, basic principles, system construction elements, capacity building elements, institutional elements, and technical means of primary health governance. It provides scientific, systematic, and operable consensus opinions and suggestions to enhance the level of primary health governance, standardize primary health governance practices, promote the equalization of primary health services, strengthen the cultivation of primary health governance talents, and drive innovation in health governance. This will provide scientific basis and recommendations to support the realization of the "Healthy China 2030".

    Reference | Related Articles | Metrics
    Interpretation of Report on Cardiovascular Health and Diseases in China 2023
    LIU Mingbo, HE Xinye, YANG Xiaohong, WANG Zengwu
    Chinese General Practice    2025, 28 (01): 20-38.   DOI: 10.12114/j.issn.1007-9572.2024.0293
    Abstract9920)   HTML241)    PDF(pc) (2424KB)(6234)       Save

    The prevalence of cardiovascular disease (CVD) in China is on the rise. It is estimated that there are 330 million people with CVD, including 13 million cases of stroke, 11.39 million cases of coronary heart disease (CHD), 8.9 million cases of heart failure (HF), 5 million cases of pulmonary heart disease, 4.87 million atrial fibrillation, 2.5 million cases of rheumatic heart disease, 2 million cases of congenital heart disease, 45.3 million cases of peripheral arterial disease (PAD), and 245 million cases of hypertension. In 2021, the total number of discharges of patients with cardiovascular and cerebrovascular diseases in China was 27 649 800, accounting for 15.36% of the total number of discharges (including all inpatient diseases) in the same period, including 14 872 300 CVDs, accounting for 8.26%, and 12 777 500 cerebrovascular diseases, accounting for 7.10%. The economic burden of CVD on residents and society still increases, and the inflection point of CVD prevention and treatment has not yet arrived.

    Table and Figures | Reference | Related Articles | Metrics